ライフサイエンスコーパス: pericardial

1 acterization and appraisal of the effects of pericardial abnormalities on cardiac performance.

2 e acquisition of a comprehensive view of the pericardial abnormalities.

3 as introduced via a deflectable sheath after pericardial access by subxiphoid puncture.

4 cular arrhythmias is often limited even when pericardial access is successful.

5 PN displacement via percutaneous pericardial access was attempted in 13 patients (age 49+

6 were 3 access-related complications (during pericardial access, n = 2; and transseptal catheterizati

7 There was no major complication related to pericardial access.

8 rapericardial delivery showed no evidence of pericardial adhesion and/or effusion or adverse effect o

9 ith prohibitive epicardial access because of pericardial adhesions (16), and anatomic barriers to abl

10 without x-ray/MR imaging (n = 3) resulted in pericardial adhesions and poor hMSC viability after 1 we

11 The pericardial adipose tissue (AT) contains a high density

12 CM from subcutaneous and pericardial adipose tissue biopsies from the same patien

13 ment of fat depots (visceral adipose tissue, pericardial adipose tissue, and periaortic adipose tissu

14 Reduction of pericardial adipose tissues is independently associated

15 rmly distributed on the epicardium following pericardial administration, displaying a half-life of 2

16 rapulmonary disease (central nervous system, pericardial among other sites) are provided.

17 MR imaging combines cardiac and pericardial anatomic assessment with tissue characteriza

18 us ethanol ablation, but 1 patient developed pericardial and pleural effusion attributed to pericardi

19 Pericardial and pleural effusions developed in one patie

20 y therapy was associated with a reduction in pericardial and systemic inflammation and LGE pericardia

21 Reversible CP was associated with pericardial and systemic inflammation.

22 owed a 4.5-fold increase in the incidence of pericardial and yolk sac edema relative to controls.

23 prevention of pericardial tamponade or intra-pericardial aortic rupture, to resect the primary entry

24 h normal systolic function undergoing bovine pericardial aortic valve replacement, the prevalence of

25 antify body length, circulation, heart rate, pericardial area (a biomarker for cardiac looping defect

26 f yolk, contortion of tails and inflation of pericardial area.

27 ll these effects was confirmed by removal of pericardial AT and ex vivo coculture with pericardial AT

28 of pericardial AT and ex vivo coculture with pericardial AT and granulocyte progenitors.

29 esponses after MI, we surgically removed the pericardial AT and performed B-cell depletion and granul

30 findings unveil a new mechanism by which the pericardial AT coordinates immune cell activation, granu

31 The relevance of the pericardial AT in mediating all these effects was confir

32 impaired dendritic cell (DC) trafficking on pericardial AT inflammatory responses was tested in CCR7

33 on fraction in CB2(-/-) mice were limited by pericardial AT removal.

34 hat activated DCs migrate from infarcts into pericardial AT via CCR7.

35 ion inhibited DC and T-cell expansion within pericardial AT, and translated into reduced bone marrow

36 -stimulating factor-producing B cells within pericardial AT, but not spleen or lymph nodes.

37 Leukocytes in murine hearts, pericardial AT, spleen, mediastinal lymph nodes, and bon

38 sociated with higher DC and T-cell counts in pericardial AT, which outnumbered DCs and T cells in lym

39 cient to assess the safety of AVR with other pericardial bioprostheses in children and the youngest a

40 ve replacement (AVR) with current-generation pericardial bioprostheses in young patients is limited.

41 median follow-up, 13.7 months) with a bovine pericardial bioprosthesis at </=30 years of age.

42 plications (pleuro-pericardial fistula 1 and pericardial bleeding 1).

43 Pericardial bleeding occurred in 4 patients with epicard

44 All patients with major bleeding had pericardial bleeding.

45 far the modality of choice for depiction of pericardial calcifications.

46 ion of the caval veins combined with ectopic pericardial cavity formation.

47 These embryos also have an expanded pericardial cell domain.

48 of reduced mesodermal Eve expression and epi/pericardial cell numbers on the maturation of the myocar

49 l cells (CCs) and the surrounding non-muscle pericardial cells (PCs), development of which is regulat

50 nding protein (RHBP) that transports heme to pericardial cells for detoxification and to growing oocy

51 Infarcted mice also had larger pericardial clusters and 3-fold upregulated numbers of g

52 To study the relevance of pericardial clusters during inflammatory responses after

53 usion (2.6%), vascular complications (2.0%), pericardial complications (1.4%), open heart surgery (0.

54 investigated common complications including pericardial complications (hemopericardium, cardiac tamp

55 ing death, stroke, intracerebral hemorrhage, pericardial complications, hematoma or hemorrhage, blood

56 Pericardial contrast injection was observed in 4 apical

57 n = 3), teratoma (n = 2), and paraganglioma, pericardial cyst, Purkinje cell tumor, and papillary fib

58 cele, ectopia cordis, distal sternal defect, pericardial defect, anterior diaphragmatic defect or int

59 We provide evidence that pericardial defects are created by abnormal localization

60 ival, adhesion, and migration, underlies the pericardial defects.

61 phila melanogaster), the expression of a key pericardial determinant, ladybird, is absent from the do

62 matory therapy, a quantitative assessment of pericardial DHE can provide incremental information to p

63 However, a quantitative assessment of pericardial DHE has not been performed, and the hierarch

64 clinical factors, inflammatory markers, and pericardial DHE is unknown.

65 When quantitative pericardial DHE was added to a model that included age,

66 estergren sedimentation rates, and increased pericardial DHE were all significantly associated with c

67 Pericarditis is the most common form of pericardial disease and a relatively common cause of che

68 Management of pericardial disease in cancer patients also posed clinic

69 s on the rapidly evolving insights regarding pericardial disease provided by modern imaging modalitie

70 ypertension, primary cardiac involvement, or pericardial disease should be reconsidered and updated.

71 Pericarditis is the most common form of pericardial disease worldwide and may recur in as many a

72 eart disease, heart failure, cardiac masses, pericardial disease, and coronary artery disease.

73 hypertension, QT prolongation, arrhythmias, pericardial disease, and radiation-induced cardiotoxicit

74 stive heart failure, valvular heart disease, pericardial disease, conduction abnormalities, and sudde

75 otoxicosis, acute alcohol consumption, acute pericardial disease, pulmonary embolism, or other acute

76 colchicine in cardiovascular medicine beyond pericardial disease.

77 have a restrictive cardiomyopathy or chronic pericardial disease.

78 atients suspected of having or known to have pericardial disease; however, cardiac computed tomograph

79 rdiac Failure, Cardiomyopathies/Myocardial & Pericardial Diseases, Congenital Heart Disease, Coronary

80 rdiac Failure, Cardiomyopathies/Myocardial & Pericardial Diseases, Congenital Heart Disease, Coronary

81 Her symptoms recurred 3 days later, and a pericardial drain was placed.

82 ly minimally invasive approach consisting of pericardial drainage and esophageal stenting proved effe

83 ics were initialized, and minimally invasive pericardial drainage and esophageal stenting were perfor

84 Diagnosis and management with pericardial drainage and esophageal stenting, as well as

85 ents were randomized to sternotomy and 56 to pericardial drainage and wash-out only.

86 Nanoparticle (NP)-based pericardial drug delivery could provide a strategy to co

87 pression by 54-81%, and induced a phenotype, pericardial edema and curled tail associated with death

88 asured by high-speed video microscopy), with pericardial edema and decreased or absent circulation [a

89 s displayed cardiac abnormalities, including pericardial edema and heart failure.

90 , with circulatory disruption culminating in pericardial edema and other secondary malformations.

91 istent with reduced heart rate and increased pericardial edema in larvae exposed to slick oil but not

92 s a more accurate predictor of lethality and pericardial edema than polycyclic aromatic hydrocarbon (

93 Mortality and pericardial edema was lowest in dilbit WAF-exposed embry

94 Pericardial edema was the most sensitive sublethal effec

95 nts exhibited hypersusceptibility to develop pericardial edema when challenged by crowding stress or

96 Zebrafish lacking sox9b showed pericardial edema, an elongated heart, and reduced blood

97 oss of the tubule brush border, reduced GFR, pericardial edema, and increased mortality.

98 ality with e12.5 embryos having exencephaly, pericardial edema, cleft palate and abnormal limb develo

99 recapitulated a heart failure phenotype with pericardial edema, decreased ventricular systolic functi

100 ediated knockdown of s1pr1 causes global and pericardial edema, loss of blood circulation, and vascul

101 brafish resulted in renal tubule defects and pericardial edema, phenotypes typically induced by kidne

102 ration barrier function, with development of pericardial edema, suggesting an important role of THSD7

103 ications were device embolization (1.9%) and pericardial effusion (1.9%), with no cases of periproced

104 %], and 10 [0.4%], respectively; P>0.05) and pericardial effusion (11 [0.4%], 11 [0.8%], and 12 [0.5%

105 ronary syndromes (ACS) (1C), the presence of pericardial effusion (1C), cardiac tamponade (1B), valvu

106 sion (12%), reticular infiltration (4%), and pericardial effusion (4%).

107 kg every 4 weeks plus tremelimumab 1 mg/kg), pericardial effusion (durvalumab 20 mg/kg every 4 weeks

108 , 1.777-6.584; P<0.001), and the presence of pericardial effusion (HR, 1.38; 95% confidence interval,

109 pericarditis post-operatively (n = 2), late pericardial effusion (n = 1), unexplained sudden death (

110 onfidence interval, 1.4-6.2; P<0.001), and a pericardial effusion (odds ratio, 2.5; 95% confidence in

111 Pericardial effusion (PE) is common in cancer patients,

112 t pain and epigastric pain was found to have pericardial effusion and pneumopericardium on computed i

113 higher risk of complications, predominantly pericardial effusion and procedural stroke related to ai

114 We report here a rare case of pericardial effusion in a pediatric patient secondary to

115 y revealed esophagopericardial fistulas with pericardial effusion in all patients, while contrast lea

116 tive model: p = 0.0161) were associated with pericardial effusion in females relative to healthy fema

117 The differential diagnosis of pericardial effusion is reviewed as well as current trea

118 Malignant pericardial effusion may require emergency pericardiocen

119 Significant pericardial effusion occurred in 16 patients (10.4%).

120 cted carbon monoxide diffusing capacity, and pericardial effusion on echocardiogram all predicted mor

121 edural stroke without increasing the risk of pericardial effusion or other bleeding complications.

122 rformed safely in the absence of preexisting pericardial effusion to provide a novel route for cardia

123 ity and only 1 hemodynamically insignificant pericardial effusion was observed at follow-up.

124 rt an unusual case of spontaneous Ureaplasma pericardial effusion with tamponade associated with pneu

125 s with preserved LVEF in 2, and an important pericardial effusion with tamponade in another.

126 Infectious pericardial effusion with tamponade is an uncommon but l

127 The rate of serious pericardial effusion within 7 days of implantation, whic

128 not otherwise specified within 30 days, one pericardial effusion) and one in consolidation phase (es

129 ation or PR depression, and new or worsening pericardial effusion).

130 re echocardiography domains (adequate views, pericardial effusion, acute cor pulmonale, left ventricu

131 int: symptomatic cardiac events (symptomatic pericardial effusion, acute coronary syndrome, pericardi

132 endpoint for safety included major bleeding, pericardial effusion, and device embolisation.

133 sia, patent ductus arteriosus, cardiomegaly, pericardial effusion, and lymphoedema.

134 e rates of death, stroke, systemic embolism, pericardial effusion, and major bleeding were 5.8%, 1.9%

135 is accompanied by hypotension and cyanosis, pericardial effusion, low voltage on the electrocardiogr

136 f mortality included age, ejection fraction, pericardial effusion, N-terminal pro-B-type natriuretic

137 rdiomyopathy, who also exhibit polycythemia, pericardial effusion, or goiter should be evaluated for

138 Four patients had bleeding complications (pericardial effusion, pericardial hematoma, hemoperitone

139 n, myocardial performance index, presence of pericardial effusion, pulmonary vascular resistance, car

140 uded bleeding- and procedure-related events (pericardial effusion, stroke, device embolization).

141 Knockdown of emp2 in zebrafish resulted in pericardial effusion, supporting the pathogenic role of

142 lar right atrial mass and moderate to severe pericardial effusion.

143 rdial rub, electrocardiographic changes, and pericardial effusion.

144 chest were obtained and indicated increasing pericardial effusion.

145 olated without steam pop, impedance rise, or pericardial effusion.

146 anized because of hypotension from a serious pericardial effusion.

147 icular dilation and dysfunction, and a large pericardial effusion.

148 more likely to have periaortic hematoma and pericardial effusion.

149 ve leaflets, and interatrial septum and mild pericardial effusion.

150 ed satisfactory device position and excluded pericardial effusion.

151 b: acute renal failure; pleural effusion and pericardial effusion; and brain metastasis.

152 s reviewed as well as current treatments for pericardial effusions and constrictive pericarditis.

153 Pericardial effusions and myocardial fibrosis were 3 and

154 c AD but is more frequently complicated with pericardial effusions and periaortic hematoma.

155 Pericardial effusions can be insidious, variable in pres

156 Pericardial effusions requiring surgical repair decrease

157 ere was a significantly higher rate of large pericardial effusions with LBN compared with MPN (8.1% v

158 There were no pericardial effusions, but serious procedure/device-rela

159 e events included hemorrhage and pleural and pericardial effusions.

160 l myocardial edema and fibrosis and frequent pericardial effusions.

161 sia, pleural effusions, chylothoraces and/or pericardial effusions.

162 critically ill with peritoneal, pleural and pericardial extension, and gastric perforation.

163 ral cavity rapidly activates mediastinal and pericardial FALCs.

164 Pericardial fat (ie, fat around the heart) may have a di

165 In men, pericardial fat (r=0.19 to 0.37, P<0.001), intrathoracic

166 In women, pericardial fat (r=0.20 to 0.35, P<0.001), intrathoracic

167 In unadjusted analyses, pericardial fat (relative hazard per 1-SD increment: 1.3

168 In view of evidence linking pericardial fat accumulation with increased cardiovascul

169 The relation between pericardial fat and coronary heart disease remained sign

170 ight and visceral adipose tissue, except for pericardial fat and left atrial dimension in men.

171 Whether the associations of pericardial fat and measures of cardiac structure and fu

172 ry calcium content, the relationship between pericardial fat and plaque eccentricity remained signifi

173 However, intrathoracic and pericardial fat are associated with vascular calcificati

174 subcutaneous adipose tissue, epicardial and pericardial fat by MRI in 75 nondiabetic men.

175 Patients with AF had significantly more pericardial fat compared with patients in sinus rhythm (

176 Pericardial fat has been implicated in the pathogenesis

177 The results support the proposed role of pericardial fat in association with atherosclerosis.

178 Myocardial triglyceride, epicardial and pericardial fat increased with increasing amount of live

179 Pericardial fat is correlated with cardiovascular magnet

180 Cross-sectional studies suggest that pericardial fat is positively associated with coronary a

181 with AF, but the relationship between AF and pericardial fat is unknown.

182 Pericardial fat is visceral adipose tissue that possesse

183 Whether pericardial fat plays a role in the pathogenesis of AF r

184 We investigated whether pericardial fat predicts future coronary heart disease e

185 Pericardial fat predicts incident coronary heart disease

186 specific long-term dietary interventions on pericardial fat tissue mobilization are sparse.We sought

187 stent AF patients had a significantly larger pericardial fat volume compared with paroxysmal AF (115.

188 Pericardial fat volume correlated significantly with deg

189 Pericardial fat volume is highly associated with paroxys

190 model (P < .05) but not after adjustment for pericardial fat volume or traditional risk factors.

191 Pericardial fat volume was associated with paroxysmal AF

192 The pericardial fat volume was determined by using computed

193 Pericardial fat volume was measured using computed tomog

194 Pericardial fat volume was significantly larger in parox

195 n coefficient analysis was used to correlate pericardial fat volume with coronary artery wall thickne

196 Pericardial fat volume, rather than BMI and waist circum

197 , myocardial fibrosis, aortic stiffness, and pericardial fat volume.

198 The volume of pericardial fat was determined from cardiac computed tom

199 Pericardial fat was positively correlated with both body

200 Intrathoracic and pericardial fat were directly correlated with body mass

201 ease, kidney disease, systemic inflammation, pericardial fat, and tobacco use.

202 Pericardial fat, but not intrathoracic fat, was associat

203 Pericardial fat, intrathoracic fat, and visceral adipose

204 Myocardial triglyceride, epicardial and pericardial fat, VAT, and subcutaneous adipose tissue in

205 derwent quantification of intrathoracic fat, pericardial fat, visceral abdominal fat (VAT), coronary

206 P=0.04), whereas intrathoracic fat, but not pericardial fat, was associated with abdominal aortic ca

207 ciation between atrial fibrillation (AF) and pericardial fat.

208 may outweigh the local pathogenic effects of pericardial fat.

209 tients developed acute complications (pleuro-pericardial fistula 1 and pericardial bleeding 1).

210 = 76), cerebral spinal fluid (CSF; n = 152), pericardial fluid (n = 131), or urine (n = 173) specimen

211 uated the diagnostic accuracy of urinary and pericardial fluid (PF) lipoarabinomannan (LAM) assays in

212 Kprest, 0.01 for the blood flow through the pericardial fluid [L/h], and 0.78 for the P-parameter de

213 The likelihood of survival if pericardial fluid and cardiac motion were both absent wa

214 rameter describing the diffusion between the pericardial fluid and epicardium [L/h].

215 te or inadequate with presence or absence of pericardial fluid and/or cardiac motion.

216 r, platelet count <20,000/mul, and malignant pericardial fluid were independently associated with poo

217 epicardium, midmyocardium, endocardium, and pericardial fluid, and accounted for cardiac metabolism

218 , 28.9% demonstrated cardiac motion and 8.6% pericardial fluid.

219 leeding complications (pericardial effusion, pericardial hematoma, hemoperitoneum, and pericardial ta

220 Mycobacterium tuberculosis culture and/or pericardial histology were the reference standard for de

221 catheter with CF sensor was introduced via a pericardial incision onto/in parallel with ventricular e

222 sonance imaging may aid in the assessment of pericardial inflammation and constriction; 3) given phen

223 athway effectors, developed profound post-MI pericardial inflammation and myocardial fibrosis, result

224 ceptable electric parameters without chronic pericardial inflammation in this canine model and offers

225 Pericardial inflammation may be a marker for reversibili

226 There was no evidence for late pericardial inflammation or effusion.

227 Pericardial inflammation was quantified on short-axis DH

228 ricardial and pleural effusion attributed to pericardial instrumentation.

229 d whether cardiac magnetic resonance imaging pericardial late gadolinium enhancement (LGE) and inflam

230 /-3%; P<0.01) and showed intramyocardial and pericardial late gadolinium enhancement.

231 a self-expanding, nitinol valve with bovine pericardial leaflets that is placed using a transapical

232 protein, erythrocyte sedimentation rate, and pericardial LGE in the group with reversible CP but not

233 Qualitative intensity of pericardial LGE was moderate or severe in 93% of the gro

234 Murine pericardial lymphoid clusters were visualized in mice su

235 s (deep and superficial subcutaneous, liver, pericardial, muscle, pancreas, and renal sinus) by magne

236 ther, these data suggest that the Drosophila pericardial nephrocyte is a useful in vivo model to help

237 IDGF2 accumulation was found at garland and pericardial nephrocytes supporting its role in organisma

238 acent to which are pairs of highly endocytic pericardial nephrocytes that modulate cardiac function b

239 ologs of nephrin and Neph1, respectively, in pericardial nephrocytes.

240 e accumulation of the fluorescent protein in pericardial nephrocytes.

241 f myocardial penetration and retention after pericardial NP drug delivery.

242 Morphological endpoints of toxicity included pericardial, ocular and yolk sac edema, nondepleted yolk

243 gical defects including hypopigmentation and pericardial oedema.

244 ent mortality with associated development of pericardial oedemas and cardiac damage.

245 y study end points were postoperative AF and pericardial or pleural effusion.

246 umin and 150 putative neuropeptides from the pericardial organs of a model organism blue crab Calline

247 struction of the neopulmonic root requires a pericardial patch encompassing two-thirds of the anastom

248 ronchus was closed by means of an autologous pericardial patch.

249 NP covalently linked to pericardial patches are a novel composite delivery syste

250 NP were covalently linked to pericardial patches using EDC/NHS chemistry and could de

251 8%; 95% CI, -2.2% to 17.6%) or postoperative pericardial/pleural effusion (colchicine, 103 patients [

252 but not of postoperative AF or postoperative pericardial/pleural effusion.

253 mL/kg for airway pressure, pleural pressure, pericardial pressure, and central venous pressure, respe

254 ssure, change in pleural pressure, change in pericardial pressure, and change in central venous press

255 Central venous pressure, airway pressure, pericardial pressure, and pleural pressure; pulse pressu

256 al electroporation ablation after subxiphoid pericardial puncture can create deep, wide, and transmur

257 with various energy levels after subxiphoid pericardial puncture.

258 chest intact in the pig model, percutaneous pericardial resection again blunted the increase in LV e

259 eline and after saline load before and after pericardial resection in normal canines with open (n=3)

260 his proof of concept study demonstrates that pericardial resection through a minimally invasive percu

261 s in obese HFpEF was associated with greater pericardial restraint and heightened ventricular interde

262 ad independent of right heart congestion and pericardial restraint, was similar in TR and controls (6

263 on clinical criteria including chest pain, a pericardial rub, electrocardiographic changes, and peric

264 nce of 2 of 4 clinical criteria (chest pain, pericardial rubs, widespread ST-segment elevation or PR

265 not function in isolation, sharing a common pericardial sac and interventricular septum.

266 ciceptors, a silicone tube was placed in the pericardial sac over the left ventricle to administer a

267 ating chest trauma by detecting blood in the pericardial sac.

268 the presence of a hemothorax and air in the pericardial sac.

269 prior to diaphragm development with dilated pericardial sacs and failure of yolk sac remodeling sugg

270 mechanics inversely correlates with adjacent pericardial segment thickness detected by cardiac magnet

271 a reference region, and then quantifying the pericardial signal that was >6 SD above the reference.

272 s demonstrate the potential of utilizing the pericardial space as a sustained drug-eluting reservoir

273 the epicardium with saline infusion into the pericardial space at 39 sites.

274 lly safe and effective, but erosion into the pericardial space or aorta has been described.

275 liver recombinant periostin peptide into the pericardial space.

276 r placement (1.9), valve surgery (9.19), and pericardial surgery (12.91).

277 The prevalence of pericardial tamponade (1%) was similar at all INRs.

278 at the vascular access site, hemolysis, and pericardial tamponade occurred in 34 (28.6%), 9 (7.5%),

279 of surgery are to save life by prevention of pericardial tamponade or intra-pericardial aortic ruptur

280 A higher rate of pericardial tamponade was observed in group A (5.2% vers

281 n, pericardial hematoma, hemoperitoneum, and pericardial tamponade).

282 Procedural complication rates included 39 pericardial tamponades (1.02%) (24 treated percutaneousl

283 or healthy controls; to assess the impact of pericardial thickening detected by cardiac magnetic reso

284 Cardiac magnetic resonance imaging LGE pericardial thickness >/= 3 mm had 86% sensitivity and 8

285 as a significant inverse correlation between pericardial thickness and respective ventricular strains

286 obal longitudinal strain to septal shift and pericardial thickness resulted in improved continuous ne

287 Baseline LGE pericardial thickness was greater in the group with reve

288 ericardial and systemic inflammation and LGE pericardial thickness, with resolution of CP physiology

289 elf-expanding nitinol valve made from bovine pericardial tissue that is 14-F compatible with a motori

290 AVR or TAVR with a balloon-expandable bovine pericardial tissue valve by either a transfemoral or tra

291 ither SAVR or TAVR with a balloon expandable pericardial tissue valve.

292 replacement with a balloon-expandable bovine pericardial valve (either a transfemoral or a transapica

293 implantation of a balloon-expandable bovine pericardial valve.

294 g patients undergoing AVR with Mitroflow LXA pericardial valves are at high risk for rapid progressio

295 derwent aortic valve replacement with bovine pericardial valves from 2004 to 2009 and had normal preo

296 ar calcification); (2) adiposity (defined by pericardial, visceral, hepatic, and intrathoracic fat);

297 ool, leading to failure to expand the dorsal pericardial wall and altered positioning of the cardiac

298 genitors comprising the proepicardium on the pericardial wall, and prevented the formation and migrat

299 th a hemopericardium confirmed at subxiphoid pericardial window (SPW), and no active bleeding, were r

300 y, and had an US scan followed by subxiphoid pericardial window exploration.